Symbol
|
ZNMLTQ | ODTRCH | ABMKSQ | ZXFLTQ | Z09MAZ | RMA4KV | Z0A61Z | Z0A6FZ | PISRCH | CLOBKB | CNMBKB | 1055BC | Z0AVGZ | RMAXZV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible with European Knock-In | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti |
Sous-jacent
|
Galenica AG / Lonza Group N / Zur Rose Group AG | Galenica AG / Roche AG / Straumann Hldg. AG | Barry Callebaut AG / Galenica AG | Baloise N / Galenica AG / Helvetia Hldg. AG / Landis+Gyr (Landis Gyr) / Swisscom N | Galenica AG / Lonza Group N / Roche GS | Galderma Group AG / Galenica AG / Tecan Group AG | Barry Callebaut AG / Galenica AG / Kühne & Nagel Intl. AG / Roche AG | Baloise N / Barry Callebaut AG / DKSH Hldg. AG / Ems-Chemie Hldg. AG / Galenica AG | Alcon / Galenica AG / Sandoz Group AG | Bachem Hldg. AG / Galenica AG / Tecan Group AG | Bachem Hldg. AG / Galenica AG / Novartis AG / Straumann Hldg. AG | Galenica AG / Nestlé S.A. / Partners Group Hldg. AG | Galenica AG / Novartis AG / Roche AG / Sonova Hldg. AG | Bayer AG / Galderma Group AG / Galenica AG / L'Oréal S.A. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
15.10.2025 | 06.05.2026 | 14.05.2025 | 24.11.2025 | 13.06.2025 | 07.04.2026 | 14.04.2026 | 14.04.2026 | 16.06.2026 | 06.07.2026 | 07.08.2026 | 13.08.2026 | 24.09.2026 | 28.09.2026 |
Demande | 30,000 | 93,69 | - | 87,79 | - | - | - | - | 97,46 | 92,54 | 91,68 | - | - | - |
Offre | 70,00 | 94,49 | - | - | - | - | - | - | 98,26 | 93,34 | 92,48 | - | - | - |